Day: April 20, 2021

CALGARY, Alberta, April 20, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) announced today the publishing of an article titled: “Bromodomain and extraterminal protein inhibitor, apabetalone (RVX-208), reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro”, in Biomedicines, a high-impact scientific journal. The previously announced findings, made in collaboration with Dr. Dalia ElGamal’s research group at the University of Nebraska Medical Center (UNMC), Omaha, NE, have completed the peer-review process. The publication can be viewed using the following LINK. “We are proud to publish our findings that have come about as part of a second world class scientific collaboration on the beneficial impact of apabetalone in reducing COVID-19 infection of lung cells, the first collaboration demonstrated...

Collaboration to use Gain’s proprietary Site-Directed Enzyme Enhancement Therapy (SEE-Tx™) computational platform technology to identify new and previously difficult-to-drug oncology targets BETHESDA, Md., April 20, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) today announced a multi-target collaboration agreement with Zentalis Pharmaceuticals (NASDAQ: ZNTL) to discover new product candidates for the treatment of cancer. Gain will use its proprietary SEE-Tx computational platform technology to identify new sites on target proteins for potential use in oncology. SEE-Tx applies a proprietary computational algorithm and supercomputer processing to the published 3D structure of proteins to discover new binding sites with the ability to modulate protein function. The intended output is newly-discovered targets...

SUGAR LAND, Texas, April 20, 2021 (GLOBE NEWSWIRE) — CVR Energy, Inc. (NYSE: CVI) plans to release its first quarter 2021 earnings results on Monday, May 3, after the close of trading on the New York Stock Exchange. The Company will host a teleconference call on Tuesday, May 4, at 1 p.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Energy’s website at www.CVREnergy.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8291. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/wo6z7ooe. A repeat of the call also can be accessed for 14 days by dialing (877) 660-6853, conference ID 13718881. CVR Energy’s first quarter...

VANCOUVER, British Columbia, April 20, 2021 (GLOBE NEWSWIRE) — Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (FRA: MY0) (the “Company” or “Myconic”) has entered into a letter of intent (“LOI”) with Tristar Wellness LLC (“Tristar”), operator of a wellness clinic in the Miami Beach area. Pursuant to the terms of the letter of intent, it is contemplated that the Company would acquire 49% of all issued and outstanding shares of Tristar. Tristar is an established clinic offering a broad scope of wellness-related treatments, including: primary care; pain management; addiction medicine; and various intravenous (IV) therapies (e.g., immune system and energy boosts). Tristar introduced ketamine infusions to its offerings in response to increasing popularity of this approach to treating conditions such as depression,...

SUGAR LAND, Texas, April 20, 2021 (GLOBE NEWSWIRE) — CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizer products, plans to release its first quarter 2021 earnings results on Monday, May 3, after the close of trading on the New York Stock Exchange. The Company will host a teleconference call on Tuesday, May 4, at 11 a.m. Eastern to discuss these results. This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Partners’ website at www.CVRPartners.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8029. The webcast will be archived and available for 14 days at https://edge.media-server.com/mmc/p/9uikt5qq. A repeat of the call also can be accessed...

CHANDLER, Ariz., April 20, 2021 (GLOBE NEWSWIRE) — To better meet the need for safe, intuitive and easy-to-use user interfaces within automotive vehicles, designers are continuing to consolidate the vehicle’s cluster, center stack and co-driver displays into very wide screens. Streamlining and simplifying system development for these ultrawide screens often seen in electric vehicles (EVs), advanced driver-assistance systems (ADAS) and premium vehicles, Microchip Technology Inc. (Nasdaq: MCHP) today announced its maXTouch®MXT2912TD-UW touchscreen controller. This is the industry’s first automotive-qualified, single-chip solution that addresses display sizes up to 45 inches with a very wide aspect ratio, supporting liquid-crystal display (LCD) and organic light emitting diode (OLED) display technologies. The MXT2912TD-UW reduces the...

BLUE ISLAND, Ill., April 20, 2021 (GLOBE NEWSWIRE) — Innovative MedTech, Inc. (the “Company”) (OTC: IMTH), a provider of health and wellness services, today announced it is trading under the new ticker symbol, IMTH. Since the recently announced acquisition of SARAH Adult Day Services, Inc. (“SarahCare”), the Company is focused on health and wellness, particularly in the independent living senior adult market.   Subsequently investors should now utilize the new ticker for trading in the company’s securitites. In addition, management provides the following additional updates:Following the recent appointment of Dr. Merle Griff as president of the company’s subsidiary, SarahCare, an adult daycare center franchise, the Company intends to aggressively expand its presence both in the U.S. and internationally. Currently in...

First study to explore potential benefit of a cannabinoid receptor type 2 agonist in SLE Study sponsored and funded by the Nastional Institute of Allergy and Infectious Diseases through the Autoimmunity Centers of Excellence (ACE) Cooperative Network Topline data expected in the second half of 2021 SLE is a serious autoimmune disease with multi-organ involvement and affects more than 200,000 AmericansNorwood, MA, April 20, 2021 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that the last participant was enrolled in a Phase 2 study of lenabasum for the treatment of systemic lupus erythematosus (SLE). The 16-week, U.S., multi-center, first-in-patient,...

ATLANTA, April 20, 2021 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced that it has launched its initial public offering of 38,236,000 shares of its common stock at an anticipated initial public offering price between $16.00 and $18.00 per share pursuant to a registration statement on Form S-1 previously filed with the U.S. Securities and Exchange Commission (“SEC”). Aveanna also intends to grant the underwriters a 30-day option to purchase up to an additional 5,735,400 shares of its common stock. Aveanna has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol “AVAH.” Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse are acting as joint lead book-running managers, and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets and Truist...

NORTHRIDGE, CA, April 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Innovative Payment Solutions, Inc. (OTCQB: IPSI) (“Innovative” or the “Company”), a Southern California based fintech company focused on building a 21st century universal digital payment platform, IPSIPay™, today announced that its Board of Directors has voted to uplist the Company’s shares on NASDAQ. William Corbett, Chief Executive Officer, commented, “These are exciting days for our company and our shareholders.  Over the past year, with the support and trust of our investment banker, our retail and institutional shareholders, we have achieved significant milestones. We have eliminated all our toxic debt, we have raised significant capital, and we have increased our shareholders value. The culmination of these achievements, along with the fulfillment...